Mega Genomics Limited (6667.HK)

9.190 -0.400 (-4.17%) As of 03:19PM HKT. Market open.

Mega Genomics Limited

401 Health Work
North Garden Road Haidian District
Beijing
China
86 40 0008 0280
https://www.megagenomics.cn

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 229

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Lin Lin	Executive Chairman	1.73M	N/A	1975
Ms. Jing Jiang	CFO & Executive Director	657.61k	N/A	1981
Dr. Rong Yu	Executive Director & Honorary Co-Chairperson	N/A	N/A	1971
Yong Zhai	Co-owner	N/A	N/A	N/A
Mr. Cong Li	Head of Information Technology	N/A	N/A	1984
Ms. Wai Kam Ng A.C.I.S., A.C.S.	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Mega Genomics Limited, a genetic testing platform company, provides consumer genetic testing, cancer screening, and other services in China. It offers general testing services comprising brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer's disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson's disease risk assessment; full-scale cancer risk assessment packages; and cardiovascular and cerebrovascular disease risk assessment packages. The company also provides advanced testing services, which include hereditary breast cancer/ovarian cancer genetic testing; Septin9 colorectal cancer screening test; andRNF180/Septin9 gastric cancer screening test, as well as executive testing services, such as personal whole genome test and whole-exome sequencing package for adults. The company serves health checkup centers, hospitals, and various other customers. Mega Genomics Limited was founded in 2016 and is headquartered in Beijing, China.

Corporate governance

Mega Genomics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.